Clinical trial recovery from COVID-19 disruption-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical trial recovery from COVID-19 disruption

Published:2020-09-10 Issue:10 Volume:19 Page:662-663
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Xue John Z.,Smietana Katarzyna,Poda Pawel,Webster Kevin,Yang Guang,Agrawal Gaurav

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.nature.com/articles/d41573-020-00150-9.pdf

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022;BMJ Oncology;2024-08

2. Impact of the COVID‐19 Pandemic on Conduct and Results of CLEAR Outcomes Trial;Clinical Cardiology;2024-07-30

3. Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions;Healthcare;2024-06-18

4. Navigating the complexities of drug development for inflammatory bowel disease;Nature Reviews Drug Discovery;2024-05-22

5. Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers;BMC Primary Care;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP